Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB)
CUSIP: 207523101
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Ordinary Shares, par value $0.000174 per share
- Shares outstanding
- 55,803,824
- Total 13F shares
- 3,947,159
- Share change
- -3,171,497
- Total reported value
- $6,867,831
- Price per share
- $1.74
- Number of holders
- 11
- Value change
- -$3,787,306
- Number of buys
- 2
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 207523101?
CUSIP 207523101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 207523101:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
5.5%
|
3,062,871
|
$3,614,188 | — | 31 Dec 2023 | |
| BML Capital Management, LLC |
13F
|
Company |
3.7%
|
2,061,438
|
$2,432,497 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.9%
|
1,040,067
|
$1,227,279 | — | 31 Dec 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
1%
|
561,191
|
$662,205 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.53%
|
298,000
|
$352,000 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
27,961
|
$32,993 | — | 31 Dec 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.03%
|
16,520
|
$19,492 | — | 31 Dec 2023 | |
| XTX Topco Ltd |
13F
|
Company |
0.03%
|
15,506
|
$18,297 | — | 31 Dec 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.02%
|
12,307
|
$14,522 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
11,405
|
$13,458 | — | 31 Dec 2023 | |
| Keudell/Morrison Wealth Management |
13F
|
Company |
0.02%
|
11,200
|
$13,216 | — | 31 Dec 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0%
|
449
|
$1,000 | — | 31 Dec 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
121
|
$143 | — | 31 Dec 2023 | |
| Qube Research & Technologies Ltd |
13F
|
Company |
0%
|
46
|
$54 | — | 31 Dec 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
23
|
$27 | — | 31 Dec 2023 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q1 2024
As of 31 Mar 2024,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) was held by
11 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,947,159 shares.
The largest 10 holders included
BML Capital Management, LLC, BlackRock Inc., OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC), RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, COMMONWEALTH EQUITY SERVICES, LLC, Keudell/Morrison Wealth Management, RHUMBLINE ADVISERS, TWO SIGMA INVESTMENTS, LP, and JPMORGAN CHASE & CO.
This page lists
11
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
14
Q1 2024 holders
11
Holder diff
-3
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.